TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/7/21 09:00 | 12/6/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 8 | 1.69 | 0 | 5 | 4 | 129 | I | |||||||||||||||
10/28/21 16:30 | 10/27/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 11 | 2.10 | 0 | 5 | 4 | 124 | I | |||||||||||||||
9/30/21 08:45 | 9/29/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 12 | 2.44 | 0 | 5 | 4 | 119 | I | |||||||||||||||
8/26/21 08:45 | 8/25/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 13 | 2.58 | 0 | 5 | 5 | 114 | I | |||||||||||||||
7/28/21 21:45 | 7/28/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 15 | 2.92 | 0 | 5 | 5 | 109 | I | |||||||||||||||
7/1/21 21:56 | 5/28/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P.am | 37 | 3.72 | 0 | 10 | 11 | 104 | M | |||||||||||||||
7/1/21 17:19 | 6/30/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 19 | 3.76 | 0 | 5 | 5 | 104 | I | |||||||||||||||
6/1/21 17:10 | 5/28/21 | VYNT | Vyant Bio, Inc. | DE | Health | Health | Medical Laboratories | Boehm Marcus | NJ | D | P | 18 | 3.68 | 0 | 5 | 5 | 99 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |